Stay updated on Safety of CAN04 and Pembrolizumab in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Safety of CAN04 and Pembrolizumab in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety of CAN04 and Pembrolizumab in Solid Tumors Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Added Revision: v3.4.3 and removed Revision: v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-11T20:15:14.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Added a site revision note (Revision: v3.4.2) and removed the previous funding-status notice and prior revision (v3.4.1). These are administrative changes to the site rather than changes to the study content.
    Difference
    0.5%
    Check dated 2026-02-11T09:21:07.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Added a government funding notice and updated the revision to v3.4.1 (replacing v3.4.0).
    Difference
    0.4%
    Check dated 2026-02-04T05:35:40.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Added a Show glossary option and minor capitalization/wording updates to UI metadata (such as QC criteria label and version text). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-01-28T04:04:34.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Summary
    Minor formatting and UI adjustments observed; core study details such as inclusion criteria, outcomes, and enrollment appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-21T04:36:00.000Z thumbnail image
  8. Check
    62 days ago
    Change Detected
    Summary
    The page shows the addition of Revision: v3.3.4 and the deletion of Revision: v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T03:14:49.000Z thumbnail image

Stay in the know with updates to Safety of CAN04 and Pembrolizumab in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety of CAN04 and Pembrolizumab in Solid Tumors Clinical Trial page.